Roche subsidiary, Foundation Medicine, is boosting its presence in the MRD testing space, which it touts as “one of the fastest-growing areas within diagnostics”.

Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast NEO, a new predictive test within its Ataraxis Breast ...

Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including two oral sessions, at the American Association for ...

Discover how a new nanophotonic chip uses genetic markers and AI to detect diseases in minutes, potentially revolutionising ...

The Trump administration has selected former deputy U.S. surgeon general Erica Schwartz as its long-awaited CDC nominee.

Invivoscribe(R) , a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the PrepQuant(TM) System, a novel sample preparation platform ...

A nanophotonic biochip combined with AI detects microRNA biomarkers in 20 minutes with high accuracy, enabling rapid, ...

A team of scientists from NTU Singapore has developed a new biochip that, when paired with artificial intelligence, can ...

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a new biochip that, when paired with Artificial Intelligence (AI), can detect quickly and accurately ...

ETHealthworld.com brings latest molecular diagnostics news, views and updates from all top sources for the Indian Health industry.

Doctors were stumped by an Oregon man’s deterioration. Then an infectious disease specialist had an aha moment.